tender for e-tender for procurement of essential drug items under table-a, for one year from the date of aoc. , amitriptyline hcl tab.i.p. 10mg. , aripiprazole tab 5 mg , cefpodoxime oral suspension 50mg/5ml , cefpodoxime proxetil 200 mg tab i.p , ciprofloxacin hcl tab. i.p. 500mg (scored ) , clindamycin inj. 600mg./ 4 ml amp/vial. , doxycyclin capsules 100mg , glimipride 2 mg tab , ibuprofen i.p. 400 mg tab. , isoniazid tab.i.p. 300mg , levetiracetam ip tab 500 mg , levetiracetam syrup 100 mg/ ml in 100 ml bottle , lignocaine hcl gel i.p 2% w/w , meropenem inj 500mg/vial , metformin tab 500 mg (sr/pr/er) , o.r.s i.p. as powder for reconstitution,cont.:sod. chloride 2.6gm.,dextrose (anhydrous13.5gms ,pot.cl 1.5 & sod.citrate 2.9gms (total 20.5per packet). , omeprazole caps.i.p. 20mg. , oseltamivir syrup ip (oseltamivir phosphate) 12 mg/ml, 75 ml phial , pantoprazole 40 mg. tab. (enteric coated) , paracetamol 1000 mg tab. , paracetamol i.p. 125 mg. tab. , paracetamol i.p. 500 mg. tab. , paracetamol i.p. 650 mg. tab. (scored) , pramipexole tab 0.25mg , prednisolone tab 10 mg , propranolol hcl tablet i.p. 10mg , propranolol hcl tablet i.p. 40mg , salbutamol syrup i.p. 2mg./5ml. , telmisartan tab 80 mg , tramadol hcl 50 mg tab. , important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender. 2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity. 3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature). 5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis. 6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).